Experience

Davis Polk advised Notre Dame Intermédica Participações S.A. in connection with the equity offering by Notre Dame Intermédica and by Bain Capital, the controlling shareholder of Notre Dame…

Davis Polk advised the joint book-running managers in connection with a Rule 144A/Regulation S offering of $500 million aggregate principal amount of 4.278% senior notes due 2028 by…

Davis Polk advised the underwriters in connection with an SEC-registered offering by Aon Corporation of $350 million aggregate principal amount of 4.500% senior notes due 2028. The…

Davis Polk advised Tongcheng-Elong Holdings Limited in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance on…

Davis Polk advised the lead managers in connection with a green bond offering by ING Groep N.V. of $1.25 billion aggregate principal amount of 4.625% fixed-rate senior notes due 2026 and €1…

Davis Polk advised CNFinance Holdings Limited on its SEC-registered initial public offering of 6,925,000 American Depositary Shares, including the partial exercise of the underwriters’…

Davis Polk advised the joint book-running managers and representatives of the underwriters on a registered public offering by Canadian National Railway Company (“CN”) of $650 million…

Davis Polk advised the initial purchasers of a Regulation S offering of high-yield notes by Scenery Journey Limited (a subsidiary of China Evergrande Group) of $565 million aggregate…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the approximately $225 million initial public offering by Orchard Therapeutics…

Davis Polk advised Tokyu Fudosan Holdings Corporation in connection with a follow-on offering of 80,436,000 shares of common stock. In addition, the underwriters have over-allotment options…